Prostate Cancer Flashcards

1
Q

Normal size of prostate gland

A

walnut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

make fluid contained in the seminal fluid which nourishes sperm

A

prostate gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Zone that surrounds proximal urethra

A

transition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Zone that surround ejaculatory ducts

A

central

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Zone that surround distal urethra and where most BPH occurs

A

peripheral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Prognosis of prostate cancer

A

5 yr survival nearly 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Racial group more often affected by prostate cancer

A

African Americans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Presenting symptoms include increased urinary frequency, painful micturition, decreased stream, hematuria, painful ejaculation

A

prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

At what level is the PSA when prostate cancer develops

A

usually above 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Factors that increase PSA

A

BPH, age, prostatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Relates PSA level to size of prostate

A

PSA density

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Change in PSA over time

A

PSA velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

low number suggests cancer, since more free PSA from normal prostate is degradated

A

Free PSA/Total PSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the levels of the Gleason scores

A

2-4 Best (cells still look normal). 5-7 Intermediate risk. 8-10 Worse (cells have few features of a normal cell and are likely to be aggressive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Therapy for T1a patient

A

if greater than 60 follow with no therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Therapy for a T1b, T1c, T2 patient

A

radical prostatectomy or high dose radiation

17
Q

Therapy for a T3 (stage 3) patient

A

radiation

18
Q

How long is the average doubling time of a prostate tumor?

A

slow, 2-4 yrs

19
Q

Nerve sparing procedure. allows neurovascular bundles on either side of prostate that control erectile fxn. Remaining Urethra is sewn to bladder neck over a catheter

A

Radical Retropubic Prostatectomy (RRP)

20
Q

Whole prostate can be examined histologically.

Surgeon has access to lymph nodes to test if prostate cancer cells have left the tumor. Surgical margin can be examined

A

Radical Retropubic Prostatectomy (RRP)

21
Q

Cannot access regional lymph nodes. Slight increase in risk of rectal injury and associated complications

A

Perineal Prostatectomy

22
Q

Radioactive seed implants into prostate. ED less common side effect

A

brachytherapy

23
Q

Maximize damage to the prostate and minimize damage to surrounding tissues. ED less common side effect

A

External Beam Radiation

24
Q

initial therapy for locally advanced or metastatic disease

A

hormonal therapy

25
Q

What hormones do prostate cells and prostate cancer cells depend on for survival and growth?

A

androgens

26
Q

may be performed prior to prostatectomy or radiation in order to shrink the tumor. standard method of treating advanced and metastatic prostate cancer

A

androgen ablation therapy (ie hormone therapy)

27
Q

surgical removal of the testicles.

A

orchiectomy (castration)

28
Q

Name the LHRH analogs

A

Goserelin (Zolodex)

Leuprolide (Lupron)

29
Q

Name the antiandrogens

A

Flutamide, bicalutamide, nilutamide

30
Q

Primary value when starting LHRH to limit the flare reaction

A

antiandrogens

31
Q

Consequences of this treatment include: impotence, decreased libido, hot flashes, weight gain, fatigue, loss of bone/muscle mass

A

androgen removal

32
Q

Treatment of hormone refractory metastatic disease

A

Docetaxel (every 3 wks), prednisone, and bisphosphonates

33
Q

Complications of anti-adrogen therapy

A

diarrhea and hepatic dysfxn

34
Q

5-alpha reductase inhibitor, blocks intracellular conversion of testosterone to dihydrotestosterone

A

Finasteride